Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
71 hedge funds and large institutions have $76.9M invested in Immune Design Corp. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 17 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less funds holding
Funds holding: 80 → 71 (-9)
29% less capital invested
Capital invested by funds: $108M → $76.9M (-$31.5M)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.88M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.06M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$807K |
| 4 |
Renaissance Technologies
New York
|
+$553K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$525K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$8.24M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.7M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$306K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$192K |
| 5 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$176K |
IMDZ Hedge Fund Activity: Q3 2018 in Review
71 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q3 2018, worth a combined $76.9M — down 29% from $108M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of IMDZ and 8 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 27 added.
The largest buyer was BVF Inc, adding an estimated $1.88M. The largest seller was EcoR1 Capital, cutting an estimated $8.24M.
- 71 institutional investors held Immune Design Corp. (IMDZ) as of Q3 2018, down from 80 in Q2 2018.
- Funds reported $76.9M of Immune Design Corp. stock for Q3 2018, down 29% quarter-over-quarter.
- 8 funds opened new Immune Design Corp. positions in Q3 2018 and 17 closed out, a net change of -9 holders.
- The largest Immune Design Corp. buyer in Q3 2018 was BVF Inc, an estimated $1.88M added.
- The largest Immune Design Corp. seller in Q3 2018 was EcoR1 Capital, an estimated $8.24M sold.
Based on aggregated 13F filings for Q3 2018.